Leslie Popplewell, MD | Hematologist

Beomjune B. Kim, DMD, MD, FACS is a head and neck oncology and microvascular surgeon at City of Hope Cancer Center Atlanta (formerly Cancer Treatment Centers of America [CTCA]). Dr. Kim provides comprehensive medical and surgical care for patients with cancer and other diseases that affect the head and neck. He is part of the team addressing the complex surgical needs of head and neck cancer patients, and those needing reconstructive surgery. "I was drawn to City of Hope because of their commitment to provide personalized cancer care through a multidisciplinary team approach, my own values are completely aligned with their philosophy on patient care, to treat patients as you would want any member of your own family treated."

Anita Johnson, MD, FACS, a breast surgical oncologist, serves as Director of Breast Cancer Center at City of Hope Atlanta. With more than 20 years of experience in breast oncology, she's been on the leading edge of advancements in health care technology and surgery, often being the first to perform innovative procedures. At City of Hope Atlanta (formerly Cancer Treatment Centers of America [CTCA]), Dr. Johnson performs oncoplastic surgery, including lumpectomies and skin-sparing and nipple-sparing mastectomies. She also performs breast ultrasounds, needle core biopsies and infusaport placements and helps patients understand the implications of genetic testing.

Kristin Higgins, M.D. is a radiation oncologist at City of Hope Cancer Center Atlanta (formerly Cancer Treatment Centers of America [CTCA]). Dr. Higgins is the Chief Clinical Officer, leading the hospital's efforts supporting advanced cancer care access and innovation, while also partnering with department chairs to lead physician recruitment and clinical growth. In her dual appointment as a Professor of Radiation Oncology for City of Hope Atlanta, she continues the clinical practice, specializing in the treatment of lung cancer. Collaborating on a team of cancer experts committed to expanding access to quality cancer care remains a driving force behind Dr. Higgins' research interest in innovative combination radiotherapy treatments.